233 related articles for article (PubMed ID: 22296749)
1. Clinical outcome after hydrothermal ablation treatment of menorrhagia in patients with and without submucous myomas.
Hachmann-Nielsen E; Rudnicki M
J Minim Invasive Gynecol; 2012; 19(2):212-6. PubMed ID: 22296749
[TBL] [Abstract][Full Text] [Related]
2. Office endometrial ablation with local anesthesia using the HydroThermAblator system: Comparison of outcomes in patients with submucous myomas with those with normal cavities in 246 cases performed over 5(1/2) years.
Glasser MH; Heinlein PK; Hung YY
J Minim Invasive Gynecol; 2009; 16(6):700-7. PubMed ID: 19896596
[TBL] [Abstract][Full Text] [Related]
3. Hysteroscopic management of large symptomatic submucous uterine myomas.
Camanni M; Bonino L; Delpiano EM; Ferrero B; Migliaretti G; Deltetto F
J Minim Invasive Gynecol; 2010; 17(1):59-65. PubMed ID: 20129334
[TBL] [Abstract][Full Text] [Related]
4. Does menstrual bleeding decrease after ablation of intramural myomas? A retrospective study.
Galen DI; Isaacson KB; Lee BB
J Minim Invasive Gynecol; 2013; 20(6):830-5. PubMed ID: 24018147
[TBL] [Abstract][Full Text] [Related]
5. The HydroThermAblator system for management of menorrhagia in women with submucous myomas: 12- to 20-month follow-up.
Glasser MH; Zimmerman JD
J Am Assoc Gynecol Laparosc; 2003 Nov; 10(4):521-7. PubMed ID: 14738642
[TBL] [Abstract][Full Text] [Related]
6. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study.
Sabbah R; Desaulniers G
J Minim Invasive Gynecol; 2006; 13(5):467-71. PubMed ID: 16962534
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy of the hysteroscopic treatment of menorrhagia associated with uterine fibromyomas].
Pellicano M; Vigorito R; Magri G; Castellano A
Minerva Ginecol; 1994 Oct; 46(10):545-9. PubMed ID: 7838410
[TBL] [Abstract][Full Text] [Related]
8. Hysteroscopic myomectomy for menorrhagia using Versascope bipolar system: efficacy and prognostic factors at a minimum of one year follow up.
Varma R; Soneja H; Clark TJ; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):154-9. PubMed ID: 19036492
[TBL] [Abstract][Full Text] [Related]
9. The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study.
Gunes M; Ozdegirmenci O; Kayikcioglu F; Haberal A; Kaplan M
J Minim Invasive Gynecol; 2008; 15(6):735-8. PubMed ID: 18971138
[TBL] [Abstract][Full Text] [Related]
10. Hysteroscopic findings in women with menorrhagia.
De Angelis C; Carnevale A; Santoro G; Nofroni I; Spinelli M; Guida M; Mencaglia L; Di Spiezio Sardo A
J Minim Invasive Gynecol; 2013; 20(2):209-14. PubMed ID: 23295199
[TBL] [Abstract][Full Text] [Related]
11. A randomised controlled trial comparing the Cavaterm endometrial ablation system with the Nd:YAG laser for the treatment of dysfunctional uterine bleeding.
Hawe J; Abbott J; Hunter D; Phillips G; Garry R
BJOG; 2003 Apr; 110(4):350-7. PubMed ID: 12699795
[TBL] [Abstract][Full Text] [Related]
12. Improving results of hysteroscopic submucosal myomectomy for menorrhagia by concomitant endometrial ablation.
Loffer FD
J Minim Invasive Gynecol; 2005; 12(3):254-60. PubMed ID: 15922984
[TBL] [Abstract][Full Text] [Related]
13. Cavaterm thermal balloon endometrial ablation versus hysteroscopic endometrial resection to treat menorrhagia: the French, multicenter, randomized study.
Brun JL; Raynal J; Burlet G; Galand B; Quéreux C; Bernard P
J Minim Invasive Gynecol; 2006; 13(5):424-30. PubMed ID: 16962526
[TBL] [Abstract][Full Text] [Related]
14. Hysteroscopic treatment of menorrhagia associated with uterine leiomyomas.
Indman PD
Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):716-20. PubMed ID: 8469459
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for the success of endometrial ablation in the treatment of menorrhagia with special reference to previous cesarean section.
Peeters JA; Penninx JP; Mol BW; Bongers MY
Eur J Obstet Gynecol Reprod Biol; 2013 Mar; 167(1):100-3. PubMed ID: 23295070
[TBL] [Abstract][Full Text] [Related]
16. Role of a bipolar resectoscope in subfertile women with submucous myomas and menstrual disorders.
Makris N; Vomvolaki E; Mantzaris G; Kalmantis K; Hatzipappas J; Antsaklis A
J Obstet Gynaecol Res; 2007 Dec; 33(6):849-54. PubMed ID: 18001453
[TBL] [Abstract][Full Text] [Related]
17. Perioperative factors for predicting successful hysteroscopic endometrial ablation.
Gemer O; Kapustian V; Kroll D; Tur-Kaspa I; Segal S
J Reprod Med; 2003 Sep; 48(9):677-80. PubMed ID: 14562630
[TBL] [Abstract][Full Text] [Related]
18. Submucous myomas: a new presurgical classification to evaluate the viability of hysteroscopic surgical treatment--preliminary report.
Lasmar RB; Barrozo PR; Dias R; Oliveira MA
J Minim Invasive Gynecol; 2005; 12(4):308-11. PubMed ID: 16036188
[TBL] [Abstract][Full Text] [Related]
19. Detection of benign intracavitary lesions in postmenopausal women with abnormal uterine bleeding: a prospective comparative study on outpatient hysteroscopy and blind biopsy.
Angioni S; Loddo A; Milano F; Piras B; Minerba L; Melis GB
J Minim Invasive Gynecol; 2008; 15(1):87-91. PubMed ID: 18262151
[TBL] [Abstract][Full Text] [Related]
20. Hysteroscopic rollerball endometrial ablation as an alternative treatment for adenomyosis with menorrhagia and/or dysmenorrhea.
Preutthipan S; Herabutya Y
J Obstet Gynaecol Res; 2010 Oct; 36(5):1031-6. PubMed ID: 20846253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
